Bullish
CRDF SEC Filings - Cardiff Oncology Inc 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Cardiff Oncology Inc. (CRDF) SEC filings, including 10-K, 10-Q, and 8-K forms, as well as insider trad...
This page provides a comprehensive resource for Cardiff Oncology Inc. (CRDF) SEC filings, including 10-K, 10-Q, and 8-K forms, as well as insider trad...
Neutral
Cardiff Oncology (CRDF) is presenting new preclinical data at the American Association for Cancer Research Annual Meeting, highlighting the efficacy o...
Cardiff Oncology's CFO, Joshua B. Muntner, was granted 486,650 stock options with an exercise price of $1.58 per share, expiring on April 6, 2036. The...